Weighing the Risks of Marketing Delta-8 and Similar Substances
Weighing the Risks of Marketing Delta-8 and Similar Substances
The reality is that the ambiguities in the 2018 Farm Bill and the lack of federal regulation of such substances have created a conundrum for those who market Delta-8 and similar substances, as well as for the cannabis industry, and for states that are weighing public safety against financial interests.
Read the article here.
Share This Story, Choose Your Platform!